Dina Jankovic

20 Article
5 Commissioned report
1 Review article

Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England
Woods, B., Kearns, B., Schmitt, L. H. M., Jankovic, D., Rothery, C., Harnan, S., Hamilton, J., Scope, A., Shijie (Kate), R., Bojke, L., Wilcox, M. H., Hope, W., Leonard, C., Howard, P., Jenkins, D., Ashworth, A., Bentley, A. & Sculpher, M., 30 Nov 2024, (E-pub ahead of print) In: Applied Health Economics and Health Policy.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model
Woods, B., Schmitt, L. H. M., Jankovic, D., Kearns, B., Scope, A., Shijie (Kate), R., Srivastava, T., Ku, C. C., Hamilton, J., Rothery, C., Bojke, L., Sculpher, M. & Harnan, S., 1 Jun 2024, In: Health technology assessment. 28, 28, p. 1-238 238 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model
Harnan, S., Kearns, B., Scope, A., Schmitt, L., Jankovic, D., Hamilton, J., Srivastava, T., Hill, H., Ku, C. C., Ren, S., Rothery, C., Bojke, L., Sculpher, M. & Woods, B., 1 Oct 2024, In: Health Technology Asssessment. 28, 73, p. 1-230 230 p.
Research output: Contribution to journal › Article › peer-review

Open Access

NIHR PHR- Which health visiting models in England are most promising for mitigating the harms of maternal related Adverse Child Experiences (ACES)?
Weatherly, H. L. A. (Principal investigator), Fox, A. (Co-investigator) & Jankovic, D. (Researcher)
1/02/22 → 31/01/26
Project: Research project (funded) › Research

Impact of the work on the prevalence and burden of medication errors in the NHS
Faria, R. (Contributor), Sculpher, M. J. (Contributor) & Jankovic, D. (Contributor)
23 Feb 2018
Activity: Other › Media (TV)

Dina Jankovic

Collaborations and top research areas from the last five years

Dive into details

Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England

Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

NIHR PHR- Which health visiting models in England are most promising for mitigating the harms of maternal related Adverse Child Experiences (ACES)?

Impact of the work on the prevalence and burden of medication errors in the NHS

Dina Jankovic

Collaborations and top research areas from the last five years

Research output

Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England

Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Projects

NIHR PHR- Which health visiting models in England are most promising for mitigating the harms of maternal related Adverse Child Experiences (ACES)?

Activities

Impact of the work on the prevalence and burden of medication errors in the NHS